A comprehensive review on thiazole based conjugates as anti-cancer agents

R Rana, N Kumar, HK Gulati, A Sharma… - Journal of Molecular …, 2023 - Elsevier
Over the past few decades, a significant number of anticancer drugs have been developed,
both natural and synthetic. Thiazole, a 5-membered distinctive heterocyclic motif with …

Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer

KA Elsayad, GF Elmasry, ST Mahmoud… - Bioorganic chemistry, 2024 - Elsevier
Sulfonamides have gained prominence as versatile agents in cancer therapy, effectively
targeting a spectrum of cancer-associated enzymes. This review provides an extensive …

Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha

K Kaur, H Verma, P Gangwar, K Jangid, M Dhiman… - Bioorganic …, 2024 - Elsevier
A series of new indole-oxadiazole derivatives was designed and synthesized to develop
potential anti-breast cancer agents. The compounds exhibited significant inhibitory activity …

Breast cancer MCF-7 cell spheroid culture for drug discovery and development

G Chen, W Liu, B Yan - Journal of cancer therapy, 2022 - pmc.ncbi.nlm.nih.gov
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …

Non-coding RNAs modulating estrogen signaling and response to endocrine therapy in breast cancer

O Treeck, S Haerteis, O Ortmann - Cancers, 2023 - mdpi.com
Simple Summary Endocrine therapy is a common treatment for estrogen-responsive breast
cancer, which is used to block the tumor growth-promoting effect of this hormone. The …

Hybridization of molecular docking studies with machine learning based QSAR model for prediction of xanthine oxidase activity

N Kumar, K Kaur, PMS Bedi - Computational and Theoretical Chemistry, 2023 - Elsevier
Xanthine Oxidase inhibitors treat hyperuricemia, but associated side effects have led
researchers to discover new inhibitors with fewer side effects. Our study employed a hybrid …

Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023)

N Kumar, K Kaur, N Kaur, E Singh, PMS Bedi - Bioorganic Chemistry, 2024 - Elsevier
Hyperuricemia, a disease characterized by elevation of serum uric acid level beyond 6
mg/dL. This elevation led to appearance of symptoms from joint pain to gout and from gout to …

Rational design, synthesis, antiproliferative activity against MCF-7, MDA-MB-231 cells, estrogen receptors binding affinity, and computational study of …

I Ejaz, MA Javed, MS Jan, M Ikram, A Sadiq… - Bioorganic & Medicinal …, 2022 - Elsevier
Based on the structural architecture of estrogen receptors (ER) agonists/antagonists, we
rationally designed and synthesized indenopyrimidine-2, 5-dione analogs as a starting point …

Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview

S Das, S Kulkarni, Y Singh, P Kumar… - Journal of Molecular …, 2022 - Elsevier
Breast cancer is a major threat to women's lives throughout the world. Hormone-dependent
or estrogen-receptor positive (ER+) breast cancer accounts for more than 80% of all …

The herbal combination Shu Gan Jie Yu regulates the SNCG/ER-a/AKT-ERK pathway in DMBA-induced breast cancer and breast cancer cell lines based on RNA …

Y Zhao, L Zhao, T Wang, Z Liu, S Tang… - Integrative Cancer …, 2024 - journals.sagepub.com
Background: Soothing the liver (called Shu Gan Jie Yu in Chinese, SGJY) is a significant
therapeutic method for breast cancer in TCM. In this study, 3 liver-soothing herbs, including …